A prospective, randomized controlled trial was performed. Between August 2011 and June 2012, 832 patients who required thyroidectomy for papillary thyroid cancer were randomized into groups treated with either the HS or the LS instrument. Operative time and surgical morbidities were analyzed.
A total of 320 patients (HS group, N聽=聽164; LS instrument group, N聽=聽156) were randomized for analysis according to the intention-to-treat principle. There were no statistically significant differences in the operative times (HS group versus LS instrument group: 71.93聽卤聽18.26 versus 75.15聽卤聽20.13; P聽=聽0.423), postoperative transient hypoparathyroidism (13.4% versus 14.1%; P聽=聽0.858), and permanent recurrent laryngeal nerve injuries between the two groups.
In this study, both hemostatic devices were safe and effective in terms of postoperative results and complications without any differences.